Startseite Non-alcoholic fatty liver disease – discussed under the light of Unani medicine
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Non-alcoholic fatty liver disease – discussed under the light of Unani medicine

  • Mohd Riyazuddin ORCID logo EMAIL logo und Arisha Shahid
Veröffentlicht/Copyright: 22. September 2021

Abstract

Non-alcoholic Fatty Liver Disease (NAFLD) is one of the diseases that have evolved lately into a major challenge for gastroenterologists. Although, the term NAFLD has not been familiar to the medical world since long, other conditions resembling the presentation of NAFLD have been there since primitive times. It is a reversible condition of the liver, wherein large vacuoles of triglyceride fat accumulates in liver cells via the process of steatosis, despite any evidence of excessive alcohol consumption. In the developed countries NAFLD is reported to be the most common liver disorder, with a worldwide prevalence of 6–35%, in India its prevalence has been increasing gradually. Unani physicians have described liver as one of the principal organs of the body. It is the primary source of natural faculties, where the functions of digestion, concoction, absorption and excretion are performed, normally temperament of liver is hot and moist which can get converted to cold due to mutable dietary habits, consumption of fatty and cold food in abundance etc. In Unani System of Medicine, NAFLD has not been described as such, but it can be studied under Su’-i-Mizāj Kabid Bārid due to correlation of most of the symptoms. Its management mainly consists of elimination of morbid matter which is accumulated in the liver and correction of Su’-i-Mizāj Kabid Bārid by using drugs having opposite temperament (Ilaj bil zid).


Corresponding author: Dr. Mohd Riyazuddin, MD Moalajat (Medicine Unani), Lecturer, Department of Moalajat (Medicine), National Institute of Unani Medicine (Under Ministry of AYUSH), Bangalore, 560091, India, Mobile: +91 8010392768, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: Not applicable.

References

1. Reddy, JK, Rao, MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 2006;290:G852–8. https://doi.org/10.1152/ajpgi.00521.2005.Suche in Google Scholar PubMed

2. Benedict, M, Zhang, X. Non-alcoholic fatty liver disease: an expanded review. World J Hepatol 2017;9:715–32. https://doi.org/10.4254/wjh.v9.i16.715.Suche in Google Scholar PubMed PubMed Central

3. Nassir, F, Rector, RS, Hammoud, GM, Ibdah, JA. Pathogenesis and prevention of hepatic steatosis. Gastroenterol Hepatol 2015;11:167–75.Suche in Google Scholar

4. Tomic, D, Kemp, WW, Roberts, SK. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies. Eur J Gastroenterol Hepatol 2018;30:1103–15. https://doi.org/10.1097/MEG.0000000000001235.Suche in Google Scholar PubMed

5. Fabbrini, E, Sullivan, S, Klein, S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010;51:679–89. https://doi.org/10.1002/hep.23280.Suche in Google Scholar PubMed PubMed Central

6. Ibn Rushd, AM. Kitabul Kulliyat, 2nd ed. New Delhi: CCRUM; 1987:26, 35, 46, 49–50 pp.Suche in Google Scholar

7. Arzani, HA. Tib e Akbar. (Urdu translation by Hakim Mohammad Hussain). Deoband: Faisal Publications; YNM, vol 2:439–42 pp.Suche in Google Scholar

8. IbnZuhr, AM. Kitab al Taiseer, 1st ed. New Delhi: CCRUM; 1986:114 p.Suche in Google Scholar

9. Tabri, AM. Moalajate Buqratiya. New Delhi: CCRUM; 1997, vol 3:202–17 pp.Suche in Google Scholar

10. Jurjani, AH. Zakheera KhwarzamShahi. New Delhi: Idara Kitabul Shifa; 2010, vol 6:371-374, 377-381 pp.Suche in Google Scholar

11. Khan, HA. Ikseer e Azam. Urdu translation by Hakim Mohammad Kabeeruddin. New Delhi: Idara Kitabul Shifa; 2011:481–98 pp.Suche in Google Scholar

12. Sina, IBN. Al Qanoon Fil Tib. Part 1. New Delhi: Idara Kitabul Shifa; YNM, vol 3:849-852, 854-864 pp.Suche in Google Scholar

13. Shah, MH. The general principles of Avicenna’s Canon of Medicine. Part 1. New Delhi: Idara Kitabul Shifa; 2007, vol 1:30 p.Suche in Google Scholar

14. Al Razi, ABMBZ. Kitab-al Hawi Fit-Tib. New Delhi: CCRUM; 2000:47–51 pp.Suche in Google Scholar

15. Khan, HA. Rumuz-e-Azam. New Delhi: CCRUM;YNM, vol 2:3–7 pp.Suche in Google Scholar

16. Al Maseehi, ASIBY. Kitabul Mi’aah. New Delhi: CCRUM; 2008, vol 1:56 p.Suche in Google Scholar

17. Zillurrahman, HS. Kitab Fil Mizaj (Jalinoos). Aligarh: IbnSina Academy; 2008:101,102,137, 126–141 pp.Suche in Google Scholar

18. de Vries, M, Westerink, J, Kaasjager, KH, de Valk, HW. Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes mellitus: a systematic review and meta-analysis. J Clin Endocrinol Metab 2020;105:3842–53. https://doi.org/10.1210/clinem/dgaa575.Suche in Google Scholar PubMed PubMed Central

19. Younossi, ZM, Marchesini, G, Pinto-Cortez, H, Petta, S. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation. Transplantation 2019;103:22–7. https://doi.org/10.1097/TP.0000000000002484.Suche in Google Scholar PubMed

20. Mitra, S, De, A, Chowdhury, A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Transl Gastroenterol Hepatol 2020;5:16. https://doi.org/10.21037/tgh.2019.09.08.Suche in Google Scholar PubMed PubMed Central

21. Carr, RM, Oranu, A, Khungar, V. Nonalcoholic fatty liver disease: pathophysiology and management. GastroenterolClin North Am 2016;45:639–52. https://doi.org/10.1016/j.gtc.2016.07.003.Suche in Google Scholar PubMed PubMed Central

22. Adams, LA, Angulo, P, Lindor, KD. Nonalcoholic fatty liver disease. CMAJ 2005;172:899–905. https://doi.org/10.1503/cmaj.045232.Suche in Google Scholar PubMed PubMed Central

23. Caldwell, SH, Argo, CK. Non-alcoholic fatty liver disease and nutrition. In: Dooley, JS, Lok, ASF, Burroughs, AK, Heathcote, EJ, editors. Sherlock’s diseases of the liver and biliary system, 12th ed. UK: Wiley-Blackwell Publication; 2011:546–61 pp.10.1002/9781444341294.ch28Suche in Google Scholar

24. Stengel, JZ, Harrison, SA. Nonalcoholic steatohepatitis: clinical presentation, diagnosis, and treatment. Gastroenterol Hepatol 2006;2:440–9.Suche in Google Scholar

25. Cobbina, E, Akhlaghi, F. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev 2017;49:197–211. https://doi.org/10.1080/03602532.2017.1293683.Suche in Google Scholar PubMed PubMed Central

26. Kirpich, IA, Marsano, LS, McClain, CJ. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem 2015;48:923–30. https://doi.org/10.1016/j.clinbiochem.2015.06.023.Suche in Google Scholar PubMed PubMed Central

27. Persico, M, Capasso, M, Persico, E, Svelto, M, Russo, R, Spano, D, et al.. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: insulin resistance and response to antiviral therapy. Hepatology 2007;46:1009–15. https://doi.org/10.1002/hep.21782.Suche in Google Scholar PubMed

28. Baghdadi, ABH. Mukhtarat Fil Tib. New Delhi: CCRUM; 2004, vol 3:268–73 pp.Suche in Google Scholar

29. Chalasani, N, Younossi, Z, Lavine, JE, Charlton, M, Cusi, K, Rinella, M, et al.. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005–23. https://doi.org/10.1002/hep.25762.Suche in Google Scholar PubMed

30. Musso, G, Gambino, R, Cassader, M, Pagano, G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43:617–49. https://doi.org/10.3109/07853890.2010.518623.Suche in Google Scholar PubMed

31. Singh, D, Das, CJ, Baruah, MP. Imaging of non-alcoholic fatty liver disease: a road less travelled. Indian J Endocrinol Metab 2013;17:990–5. https://doi.org/10.4103/2230-8210.122606.Suche in Google Scholar PubMed PubMed Central

32. Adam, A, Dixon, AK, Grainger, RG, Allison, DJ. Grainger & Allison’s diagnostic radiology, 5th ed. China: Elsevier Publication; 2008, vol 1:731–2 pp.Suche in Google Scholar

33. Subbarao, K, Banerjee, S, Aggarwal, SK, Bhargava, SK. Diagnostic radiology and imaging, 2nd ed. New Delhi: Jaypee Brothers; 2003, vol 1:495–6 pp.Suche in Google Scholar

34. Firdaus, HHAK. Majmaul Behrain. Lucknow: Munshi Naval Kishor;YNM:411–3 pp.Suche in Google Scholar

35. Ali, SA. Tarjuma Zakheera Sabit Ibn Qurrah. Aligarh: Lithocolour Printers; 1987:239–40 pp.Suche in Google Scholar

36. Al Tabri, ABSR. Firdausal Hikmat. New Delhi: IdaraKitab us Shifa; 2010:207–208, 209 pp.Suche in Google Scholar

37. Khare, CP. Indian medicinal plants- an illustrated dictionary. New Delhi: Rajkamal Electric Press; 2007:63, 178, 191, 271, 284, 586, 694 pp.10.1007/978-0-387-70638-2Suche in Google Scholar

38. Abdul Hakim, HM. Bustanul Mufradat. New Delhi: Idara Kitabul Shifa; 2002:66, 73, 95, 118, 316, 400, 516 pp.Suche in Google Scholar


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jcim-2021-0296).


Received: 2021-07-08
Accepted: 2021-09-05
Published Online: 2021-09-22

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Reviews
  3. Does acupuncture improve sexual dysfunction? A systematic review
  4. Non-alcoholic fatty liver disease – discussed under the light of Unani medicine
  5. Phytochemistry and pharmacology of Celastrus paniculatus Wild.: a nootropic drug
  6. Low back pain patients’ perceived effectiveness of utilizing complementary and alternative medicine: a systematic review of qualitative studies
  7. Efficacy and tolerability of Lavandula angustifolia in treating patients with the diagnosis of depression: a systematic review of randomized controlled trials
  8. Research Articles
  9. Psychobiotic interventions attenuate chronic alcohol use-mediated exacerbation of posttraumatic stress disorder in rats: the role of gut-liver axis response
  10. Evaluation of the toxicity of crude aqueous Pleurotus tuber-regium (Fr.) Singer extract in mice
  11. Effects of crude methanol extract of Adansonia digitata fruit pulp on Naja nigricollis venom-induce toxicity in Wistar rats
  12. Integrative medicine approaches to chronic depression: case studies of the recovery process with a three-step path to recovery and significant cure
  13. Antimicrobial, anti-adhesion, anti-biofilm properties of goji berry (Lycium barbarum) against periodontal bacteria: potential benefits for periodontal diseases
  14. Method development and validation for quantification of six bioactive compounds (andrographolide, columbin, piperine, gallic, paracoumaric and oleanolic acids) by HPTLC
  15. Gallic acid a flavonoid isolated from Euphorbia hirta antagonizes gamma radiation induced radiotoxicity in lymphocytes in vitro
  16. Naturopathic knowledge and approaches to managing endometriosis: a cross-sectional survey of naturopaths with experience in endometriosis care
  17. Halimeda gracilis (Kadarpassi chooranam) Phytochemical analysis and biological significance – a novel Siddha drug
  18. Trends in the St. John’s wort (Hypericum perforatum) research literature: a bibliometric analysis
  19. Use and perception of complementary and alternative medicine among Iranian psychologists
  20. Innovative histological and histochemical characterization of tongue biopsies from patients with burning mouth syndrome
  21. A randomized, double-blind, placebo-controlled, cross-over trial to evaluate the effect of EstroSense® on 2-hydroxyestrone:16α-hydroxyestrone ratio in premenopausal women
  22. Comparing the influence of foot reflexology and fasting mimicking diet on quality of life and sleep quality in obesity hypoventilation syndrome
  23. The effects of Cynodon dactylon (Poaceae family) and Dolichos biflorus (Fabaceae family) extracts on decreasing size and excretion of kidney and urinary tract stones: a randomized, double-blind controlled trial
  24. Role of Bifidobacterium spp. intake in improving depressive mood and well-being and its link to kynurenine blood level: an interventional study
  25. A randomized controlled clinical trial to evaluate safety and efficacy of a Unani formulation in the management of Kalaf (Melasma)
  26. Impact of yoga and physical exercise on psychological wellbeing among substance abusers: a randomized controlled trial
  27. A non-inferiority randomized controlled clinical trial comparing Unani formulations and PUVAsol in non-segmental vitiligo
  28. Efficacy of individualized homeopathic medicines in primary dysmenorrhea: a double-blind, randomized, placebo-controlled, clinical trial
  29. A comparative study of chemical constituents and safety of Thai herbal medicated oil formula and traditional medicated oil
  30. Efficacy of Ayurvedic treatment protocol in gouty arthritis – a clinical study
  31. Knowledge, attitude and perception of complementary and alternative system of medicine in Tamilnadu and Pudhucherry, South India
  32. Discussion Forum
  33. Time to say good-bye? Homeopathy, skeptics and thoughts on how to proceed
  34. Congress Abstracts
  35. 2022 INCAM Research Symposium
Heruntergeladen am 7.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jcim-2021-0296/html
Button zum nach oben scrollen